High Efficacy and Safety of Flat-Dose Ribavirin Plus Sofosbuvir/Daclatasvir in Genotype 3 Cirrhotic Patients.
Authors: Pellicelli A et al
Date: May 20
Scope of interest: infectious/hepatological
Authors: Pellicelli A et al
Date: May 20
Scope of interest: infectious/hepatological
Authors: Fiorelli E., Lanti A., Ferraro A.S., D’Alessandro E., Chiru O.M., Del Proposto G., Cerrone P., De Angelis L., Guiducci G., Zinno F., Adorno G., Isacchi G., “ Plerixafor in association with G-CSF as a mobilization regimen in patients
Date: 2014
Scope of interest: Clinical pathology
Authors: Bustacchini S, Corsonello A, Onder G, Guffanti EE, Marchegiani F, Abbatecola AM, Lattanzio
Date: 2009
Scope of interest: pharmacology, ageing
Authors: Fiorelli E, Lanti A, Docimo F, Adorno G
Date: 2014
Scope of interest: CLINICAL PATHOLOGY
Click on the icon of the service you are looking for and go to the dedicated section. If the service is not in the selection, go to Service Guide